Abstract
<P>The main goal of treatment for obsessive-compulsive disorder (OCD) is to reduce the severity and the intrusiveness of obsessions and compulsions so as to improve the patient’s quality of life. This article reviews current pharmacologic treatments for OCD, including a comprehensive review of the literature regarding the effectiveness of various agents, as well as their side effects and factors affecting treatment response in individual patients.</P> <H4>ABOUT THE AUTHORS</H4> <P>Dr. Marazziti is professor of psychiatry, Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Pisa, Italy. Dr. Catena is resident, Università degli Studi Firenze, [LOCATION]. Dr. Pallanti is professor of psychiatry, University of Florence, Florence, Italy, and Mount Sinai School of Medicine, New York, NY. </P> <P>Address reprint requests to: Dr. Donatella Marazziti, Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, via Roma, 67, I-56100 Pisa, Italy; or e-mail <a href="mailto:dmarazzi@psico.med.unipi.it">dmarazzi@psico.med.unipi.it</a>. </P> <P>The authors disclosed no relevant financial relationships.</P>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
